• Prevotella copri Modulates Breast Cancer via Tryptophan Meta

  2026-05-18

  This study uncovers how enrichment of Prevotella copri in the gut microbiota accelerates breast cancer progression by depleting host indole-3-pyruvic acid (IPyA), an intrinsic anti-cancer metabolite. Mechanistically, these changes in tryptophan metabolism inactivate AMPK signaling via UHRF1-mediated regulation, highlighting a novel microbial-metabolic axis in breast cancer pathogenesis.

• VER 155008: Adenosine-Derived HSP 70 Inhibitor for Cancer Re

  2026-05-18

  VER 155008 is a potent HSP 70 inhibitor that disrupts chaperone-mediated pathways, induces apoptosis, and impairs cancer cell proliferation in vitro. Its mechanism centers on selective ATPase inhibition within the Hsp70 family. This small molecule is a critical tool for apoptosis assays and mechanistic studies in oncology.

• High Viscosity Induces P-gp Mediated Chemoresistance in Canc

  2026-05-17

  This study demonstrates that elevated extracellular fluid viscosity in the tumor microenvironment directly upregulates P-glycoprotein (P-gp) expression, conferring chemoresistance in cancer cells. The findings reveal a mechanotransduction pathway involving cytoskeletal remodeling, TRPV4 activation, and YAP signaling, highlighting new avenues for targeting mechanical cues in drug resistance research.

• PEGylated Iron Oxide Nanoparticles: Hepatic Cellular Interac

  2026-05-16

  This study systematically dissects how the size and PEGylation of iron oxide nanoparticles govern their uptake by specific liver cell populations. The findings challenge prevailing assumptions about nanoparticle clearance, offering new guidance for designing nanomedicines with improved tissue targeting and reduced hepatic accumulation.

• Chlorpromazine Hydrochloride: Applied Antipsychotic Research

  2026-05-15

  Chlorpromazine hydrochloride is a cornerstone of neuropharmacology, enabling robust experimental modeling of dopamine receptor signaling and antipsychotic efficacy. Here, we synthesize best-practices and troubleshooting strategies—anchored in recent breakthroughs on nanoparticle-liver interactions—to help researchers harness Chlorpromazine’s full translational value in CNS and hepatic cross-talk studies.

• Prevotella copri’s Role in Breast Cancer Progression via IPy

  2026-05-15

  This study reveals how enrichment of Prevotella copri in gut microbiota accelerates breast cancer progression by depleting host indole-3-pyruvic acid (IPyA), leading to AMPK inactivation through UHRF1-mediated pathways. The findings highlight a mechanistic link between gut microbial composition and tumor-promoting metabolic shifts, opening avenues for translational research in cancer-microbiome interactions.

• PXR Activation Regulates Urine Concentration via Hypothalami

  2026-05-14

  This study uncovers a novel physiological role for the pregnane X receptor (PXR) in water homeostasis, demonstrating that PXR activation enhances urine concentration by upregulating hypothalamic arginine vasopressin (AVP) expression. These findings expand the biological context of PXR beyond its established role in xenobiotic metabolism and hepatic detoxification.

• THZ1: Covalent CDK7 Inhibitor Workflows in T-ALL Research

  2026-05-14

  THZ1 delivers precise transcriptional control as a covalent CDK7 inhibitor, uniquely overcoming resistance seen with non-covalent inhibitors in cancer research. This guide translates advanced experimental workflows and troubleshooting strategies for robust, reproducible T-ALL and cancer biology applications.

• Promethazine HCl (SKU B4784): Enhancing Cell Assay Reliabili

  2026-05-13

  This article addresses critical laboratory challenges in cell viability and immunology assays, focusing on how Promethazine HCl (SKU B4784) from APExBIO delivers reproducible, mechanistically validated results. Integrating recent research and workflow best practices, it guides biomedical researchers in optimizing experimental outcomes using this high-purity phenothiazine derivative.

• Pentoxifylline: Mechanisms, Protocols, and Research Benchmar

  2026-05-13

  Pentoxifylline is a non-specific phosphodiesterase inhibitor with well-characterized anti-inflammatory and immunomodulatory actions. It downregulates pro-inflammatory cytokines and is widely used in research models for inflammation, circulation, and immune modulation. This article details its mechanisms, validated protocols, and practical boundaries for scientific use.

• Advancing In Vitro Cancer Drug Response Metrics: Insights fr

  2026-05-12

  Schwartz’s dissertation systematically redefines how anti-cancer drug responses are measured in vitro, emphasizing the non-equivalence of cell viability and cell death metrics. This nuanced approach has direct implications for the design, interpretation, and translational relevance of apoptosis inhibitor research.

• THZ1: Covalent CDK7 Inhibitor Empowering T-ALL & Cancer Biol

  2026-05-12

  THZ1, a selective covalent CDK7 inhibitor from APExBIO, redefines transcription regulation and cancer biology workflows with nanomolar potency and durable target engagement. This guide unpacks advanced assay setup, protocol optimization, and troubleshooting for researchers seeking robust, reproducible results in T-ALL and broader cancer research.

• YAP-TEAD Regulation of Super-Enhancers in Surface Ectoderm F

  2026-05-11

  Wang et al. (2026) dissect the regulatory role of YAP-TEAD in orchestrating super-enhancer (SE) networks during early surface ectodermal commitment from pluripotent stem cells. Their integrative approach illuminates how chromatin landscape remodeling and key transcription factor interactions drive lineage specification, with implications for regenerative and developmental biology.

• Hepatic Cellular Interactions of PEGylated Iron Oxide Nanopa

  2026-05-11

  This study elucidates how PEG chain length and iron oxide nanoparticle size modulate hepatic cellular uptake, challenging conventional assumptions about Kupffer cell dominance in liver sequestration. Findings offer actionable guidance for optimizing nanoparticle design to minimize off-target hepatic accumulation and improve nanomedicine delivery specificity.

• 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine i

  2026-05-10

  Harnessing 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine as a selective α2-adrenergic receptor agonist transforms post-surgery osteosarcoma recurrence studies. This guide delivers actionable protocols, advanced use-cases, and troubleshooting strategies, all grounded in the latest translational research.

454 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page